Zoll gets US nod for paediatric AED (automated external defibrillator):
This article was originally published in Clinica
Executive Summary
Zoll Medical has gained US FDA 510(k) marketing clearance for a paediatric capability for its automated external defibrillator, AED Plus. This capability, for children up to eight years of age, includes voice prompts that tell rescuers what type of electrodes - adult or paediatric - are connected. This ensures that the proper electrodes and specific heart rhythm analysis algorithms for adults and children are used. Paediatric-specific energy levels are also incorporated in the device. "The [paediatric] capability allows us to approach more than 14,500 US public school districts and more than 27,000 private schools," said Richard Packer, the Chelmsford, Massachusetts firm's president and CEO.